Prime Medicine Wins Arbitration Against Beam

Companies Prime Medicine, Inc. (Nasdaq: PRME) vs. Beam Therapeutics, Inc. (Nasdaq: BEAM) Event Type IP / legal — binding arbitration resolution in favor of Prime Medicine Modality Prime editing — in vivo correction via universal liver lipid nanoparticle (LNP) delivery Target SERPINA1 gene — E342K…